Protein kinase CKII (i.e. casein kinase 11, CKII, NII) is expressed at a higher level in rapidly proliferating tissues and in solid human tumours (e. g. colorectal carcinomas) when compared to the corresponding nonneoplastic colorectal mucosa. This could be shown by (a) Western blotting of cellular extracts from solid tumours followed by immunostaining with an anti-CKII polyclonal antibody, (b) immunohistochemical staining of cells from tissue sections and (c) by activity measurements using the CKII-specific synthetic peptide (RRRDDDSDDD). The maximum observed activity in the colorectal carcinomas investigated was up to eightfold higher in the tumour specimens than in the non-neoplastic tissue (i.e. colorectal mucosa). The activity range was between 33 -350 U/ mg protein and in the case of colorectal mucosa 13 -106 U/mg protein. The amount of CKII determined in the individual tumours was in the range 0.4-1.6 nmol/g tissue.Casein kinase I1 (CKII) is found in the cytoplasm and in the nucleus. The latter form has also been called NII, although biochemical and biophysical data suggest that it is the same enzyme. The name is misleading inasmuch as the name casein kinase I1 was coined according to its test substrate which is casein.CKII is a ubiquitous protein kinase which is widely distributed in different eukaryotic cell types [I]. The level of enzyme activity has been shown to be elevated in transformed cells [2], in mitogen-stimulated lymphocytes [3], during mouse embryogenesis [4], during differentiation of 3T3-LI cells [5] and during progesterone-induced maturation of oocytes [6]. All these findings suggest a functional role for CKII in the regulation of cellular growth. In detail, CKII has been thought to play a role in the regulation of protein synthesis 141. By immunohistochemical studies, CKII was shown to be highly concentrated in the nucleolus [15, 161, i.e. in the same cellular compartment where some of its potential physiological substrates (RNA polymerase I, topoisomerases I and 11, and nucleolin) are located. These nucleolar proteins are involved in the first steps of cellular growth and CKII seems to be the key enzyme controlling the very first steps of proliferation at the level of rRNA synthesis. Here we demonstrate that CKII is elevated in human solid tumours when compared to nonneoplastic tissue of the same patient. The results are supported by immunohistochemical studies. In addition, we have shown that CKII is not exclusively elevated in tumour cells but also in normal tissue with high mitotic activity (e. g. colorectal mucosa).Thus the data presented are in good agreement with earlier studies, where elevated CKII activity was detected in tumour cell lines [2] and also in non-neoplastic tissue (e.g. during certain stages of embryogenesis) [4]. A comparison with the proliferation marker Ki67 [I71 also suggests that there may be a potential application for CKII as a marker protein for proliferation.
MATERIALS AND METHODS
Breast carcinomasA tumour and non-neoplastic tissue from a patient with an i...